Skip to content

Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07138963
Enrollment
25
Registered
2025-08-24
Start date
2024-06-30
Completion date
2026-06-30
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Muscular Dystrophies, Congenital Myopathies, Correction, Egyptian Patients, Genotype, Phenotype, Sample

Brief summary

The aim of this study is to correlate the phenotype and genotype among a sample of Egyptian patients with Congenital myopathies and Congenital muscular dystrophies.

Detailed description

Congenital Muscular dystrophies (CMDs) and Congenital Myopathies (CMs) constitute the two most important groups of congenital muscle diseases with early onset whether at birth or early infancy. CMDs and CMs as a group encompass great clinical and genetic heterogeneity so that achieving an accurate genetic diagnosis has become increasingly challenging, even in the era of next generation sequencing. However, it has become clear that there is overlap between CMDs and CMs on the clinical, pathological and genetic level.

Interventions

DIAGNOSTIC_TESTGenetic Testing and Muscle Biopsy

Comprehensive diagnostic assessment including clinical examination, electromyography (EMG), muscle biopsy for histopathological evaluation, and genetic testing to determine phenotype-genotype correlation in congenital myopathies and muscular dystrophies.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with clinical criteria of Congenital Myopathies (CMs) and Congenital Muscular dystrophies (CMDs) with different modes of inheritance. * Age: patients below age of 18 years. * Gender: Both males and females are included * Genetically confirmed CMs and CMDs.

Exclusion criteria

* Patients above 18 years. * Spinal muscular atrophy (SMA),and root lesions. * Congenital myasthenic syndromes * Dystrophinopathies,Duchenne Muscular Dystrophy (DMD), Limb-Girdle Muscular Dystrophy (LGMD) * .Metabolic myopathies * .Inflammatory muscle diseases

Design outcomes

Primary

MeasureTime frameDescription
Phenotype and genotype of congenital myopathies (CM) and congenital muscular dystrophies (CMD) patientsTwo yearsCorrelation of the most common clinical presentations and complications among Egyptian patients with congenital myopathies (CM) and congenital muscular dystrophies (CMD) of different genotypes.

Secondary

MeasureTime frameDescription
Common facial featuresTwo yearsIdentification and comparison of typical dysmorphic facial features associated with different genetic subtypes of congenital myopathies (CM) and congenital muscular dystrophies (CMD).
Response to physiotherapyTwo yearsResponse to physiotherapy will be recorded.
Prognosis of same genotype across different age groupsTwo yearsThe prognosis of the same genotype across different age groups will be recorded.

Countries

Egypt

Contacts

Primary ContactNouran M Sabry, MSc
nouran.abdelaziz@med.asu.edu.eg00201092289982

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026